Mohammad Ammar Abdulrazzak, MD
Vascular Neurology · Cleveland, OHNPI 1982068136
Payments from drug & device makers
What this record shows
Stryker accounts for 70.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $2,578 and has fallen 87.6% since, to $320 in 2025.
Across 34 payments — averaging $102.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medtronic$351
- Microvention, Inc.$280
- Johnson & Johnson$131
- Jazz Pharmaceuticals Inc.$112
- Route 92 Medical, Inc.$48
- plus $99 from 4 others
What the payments were for
- Travel & lodging$1,88054%
- Food & beverage$1,59446%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 14 | $2,452 |
| Medtronic | 8 | $351 |
| Microvention, Inc. | 4 | $280 |
| Johnson & Johnson | 2 | $131 |
| Jazz Pharmaceuticals Inc. | 1 | $112 |
| Route 92 Medical, Inc. | 1 | $48 |
| Scientia Vascular | 1 | $38 |
| Cardiva Medical, Inc. | 1 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Penumbra, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TARGET$1,290
- AXS CATALYST 7$530
- AXS VECTA 71$358
- STENT$345
- Pipeline$286
- TREVO$138
- WEB Aneurysm Embolization System$119
- Azur CX Detachable$119
- LVIS JUNIOR$119
- SOFIA 6F-131CM STR$113
- XYREM$112
How this compares
$3,474 in reported general payments places this provider in the 55th percentile of 43 vascular neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular neurology in Cleveland
- Muhammad HussainCleveland$105K
- Gabor TothCleveland$34K
- Jenny Peih-Chir TsaiCleveland$27K
- Anas AlrohimiCleveland$8K
- Hyeyoung SeolCleveland$1K
- Ken UchinoCleveland$397
- Marco Gonzalez CastellonCleveland$274
- Dolora WiscoCleveland$207
- Maria SokolaCleveland$165
- Mohammad Jamil AhmadCleveland$161
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.